A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
about
An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo.Curative effect of the recent photofrin photodynamic adjuvant treatment on young patients with advanced colorectal cancerObesity and Cancer: An Angiogenic and Inflammatory Link.Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis.In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics.EGFR-targeting peptide-coupled platinum(IV) complexes.Apoferritin as an ubiquitous nanocarrier with excellent shelf life.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives.Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agentsSynergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers.Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration.Therapeutic targeting of non-coding RNAs in cancer.Polymer therapeutics and the EPR effect.Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model.Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma.Capturing "Extraordinary" Soft-Assembled Charge-Like Polypeptides as a Strategy for Nanocarrier Design.Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.Nanotherapeutics for multiple myeloma.Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment.Polysaccharide-Based Controlled Release Systems for Therapeutics Delivery and Tissue Engineering: From Bench to Bedside.Functional responsive superparamagnetic core/shell nanoparticles and their drug release propertiesZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapyEngineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in TumorImmunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
P2860
Q33615268-FEF89EF7-E571-49B1-ABD1-7BDB9719C3B8Q35964452-9A94E44F-3836-4472-B65C-B4E2789A14CCQ36759129-8DA53FAC-EE6B-4E2B-8718-841CCB2A10B5Q37175322-AFF8FA22-390C-4E18-AD34-8687EDAAF661Q38405765-706B3F67-21C4-44CE-849D-F7C788F22C8BQ38689637-0C8D931D-CDCA-4CC7-8E6E-4217C7636563Q38707872-03DDBAAF-79AA-4C53-9D68-0E8EDBD1BD99Q38708389-B04F2CE1-1B81-498E-B16F-EFE66636A5A5Q38755295-34B34DF3-8843-4E06-8226-C2A7D7215FE7Q38854876-D04F87B4-E0FE-44B3-AC97-341932426FE7Q38957484-153DFF4E-6874-43DA-B77A-0BB00FC20DD8Q39310603-3C71EF26-1ECD-4D32-88F6-296355492CE2Q41448543-B12882B0-B8EC-4E4E-ADB6-2A86DA3A02E0Q46914962-EF56C881-61B9-4725-B8FC-3BB0F53F8BF3Q47182893-EEF4336A-232B-48D0-88F9-DAA8438B5203Q47292099-E6680AD8-4DE4-4C89-A142-337CAD711628Q47681427-026299F2-56F6-496A-83D3-99D5D9B60109Q47862334-464C1030-C6F1-4A9D-BD62-DD803DCD95E8Q48132164-72C5A5D6-EA2F-40F2-938A-56756D720F75Q48684399-279D716D-D92F-4C8E-A76B-8EF0EFBE7857Q51763013-459D8860-631A-4731-ACF5-47CE34A54457Q52559684-86E14F1B-980D-42AD-B4E3-5233F1B79F44Q52707854-A45E7F1C-EFDA-48BF-9EBB-26CA37A79645Q54958449-9E4B8846-69E1-468C-A2DD-A56CB2542AC8Q57368022-1B2D7918-3D27-4759-9250-12612F1E606BQ57470024-6EDE404D-9F67-4538-97A2-DE6670BF9E18Q58552610-F11CD4AD-EC0F-458D-BA86-5847EFD94EC9Q58705140-9092492A-8D0E-4629-A926-6A632143295D
P2860
A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Retrospective 30 Years After ...... ems, Solutions, and Prospects.
@en
type
label
A Retrospective 30 Years After ...... ems, Solutions, and Prospects.
@en
prefLabel
A Retrospective 30 Years After ...... ems, Solutions, and Prospects.
@en
P2093
P2860
P356
P1433
P1476
A Retrospective 30 Years After ...... ems, Solutions, and Prospects.
@en
P2093
Hiroshi Maeda
Kenji Tsukigawa
P2860
P304
P356
10.1111/MICC.12228
P577
2015-08-03T00:00:00Z